FBXO9 and lung carcinoma: Importantly, the direct inhibition of FBXO9-mediated ATP6V1A ubiquitination by an interaction inhibitory peptide not only prevents cancer cell migration and sphere formation (Fig. 4H-N) but also hinders the metastasis of lung cancer cells in a mouse model (Fig. 4O and P).